Announcements Trials
Browse Landscape

Phase

Phase 4 2Phase NA 1Phase 1 1

Status

Withdrawn 1Unknown 1Terminated 1Completed 1

Sponsor Class

OTHER 4

Study Type

Interventional 4

Sponsor

Cancer Type

Gynecologic 2Breast 2Head & Neck 1Dermatologic 1

Conditions

Ovarian Neoplasms 2Breast Neoplasms 2Melanoma 1Head and Neck Neoplasms 1

Interventions

Cyclophosphamide 3162Cisplatin 3160Carboplatin 2938Paclitaxel 2673Radiotherapy 2648Gemcitabine 2547pembrolizumab 2331Docetaxel 2157Bevacizumab 2128Fluorouracil 1822Capecitabine 1784Oxaliplatin 1713Dexamethasone 1590Nivolumab 1517Doxorubicin 1477Rituximab 1454Etoposide 1342Magnetic Resonance Spectroscopy 1266Irinotecan 1235Leucovorin 1216Cytarabine 1123Pemetrexed 1062Drug Therapy 1062fludarabine 1050Vincristine 956Specimen Handling 936Prednisone 926Cetuximab 921Lenalidomide 916Trastuzumab 902

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Interventional × technetium Tc 99m nanocolloid × Clear all
NCT04487912 2021-05-14

Dynamics and Tracer Distribution of Tilmanocept in Early Stage Breast Cancer

University Hospital, Ghent

Phase 4 Withdrawn
Breast

Breast Neoplasms

NCT02540551 2020-03-24

SONAR-2

Maastricht University Medical Center

Phase 1 Terminated
11 enrolled
Gynecologic

Ovarian Neoplasms

NCT04261179 2020-02-20

SENTINELSEEK

Fundacion Clinic per a la Recerca Biomédica

Phase 4 Unknown
30 enrolled
BreastDermatologicHead & Neck

Breast Neoplasms, Head and Neck Neoplasms, Melanoma

NCT01734746 2018-11-05

SONAR

Maastricht University Medical Center

Phase NA Completed
22 enrolled 6 charts
Gynecologic

Ovarian Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡